Drug
Odm 209
Odm 209: highest development phase Phase 1/2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-209 NCT03878823 | Phase 1/2 | Prostate Cancer Metastatic |
Latest
No recent events.
Follow Odm 209 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.